Your Input: | |||||
WNT6 | Protein Wnt-6. (364 aa) | ||||
DLL4 | Delta-like protein 4. (685 aa) | ||||
WNT10A | Protein Wnt-10a. (417 aa) | ||||
PIK3CA | Phosphatidylinositol 4. (1068 aa) | ||||
PGR | Progesterone receptor. (919 aa) | ||||
AKT1 | RAC-alpha serine/threonine-protein kinase isoform X1. (480 aa) | ||||
SOS2 | Son of sevenless-like protein 2. (1332 aa) | ||||
CDK6 | Cyclin-dependent kinase 6. (365 aa) | ||||
WNT2B | Protein Wnt-2b. (393 aa) | ||||
ESR2 | Estrogen receptor beta. (531 aa) | ||||
NOTCH1 | Neurogenic locus notch-like protein 1. (2556 aa) | ||||
FOS | Proto-oncogene c-Fos. (380 aa) | ||||
POLK | DNA polymerase kappa. (878 aa) | ||||
HEY2 | Hairy/enhancer-of-split related with YRPW motif protein 2. (337 aa) | ||||
WNT8A | Protein Wnt-8a. (370 aa) | ||||
KIT | Mast/stem cell growth factor receptor Kit isoform X1. (976 aa) | ||||
WNT2 | Protein Wnt-2. (360 aa) | ||||
FGF5 | Fibroblast growth factor 5 isoform X1. (270 aa) | ||||
FGF21 | Fibroblast growth factor 21. (209 aa) | ||||
MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1. (393 aa) | ||||
NOTCH2 | Neurogenic locus notch-like protein 2. (2471 aa) | ||||
DVL3 | Segment polarity protein dishevelled-like protein DVL-3. (669 aa) | ||||
FGF2 | Fibroblast growth factor 2. (278 aa) | ||||
BAX | Apoptosis regulator BAX. (205 aa) | ||||
CSNK1A1 | Casein kinase I isoform alpha. (365 aa) | ||||
TCF7 | Transcription factor 7. (354 aa) | ||||
WNT9B | Protein Wnt-9b. (372 aa) | ||||
WNT11 | Protein Wnt-11. (354 aa) | ||||
WNT16 | Protein Wnt-16. (362 aa) | ||||
FZD2 | Frizzled-2. (509 aa) | ||||
SHC1 | SHC-transforming protein 1. (584 aa) | ||||
WNT7A | Protein Wnt-7a. (349 aa) | ||||
FLT4 | Vascular endothelial growth factor receptor 3. (1356 aa) | ||||
MAP2K2 | Dual specificity mitogen-activated protein kinase kinase 2. (401 aa) | ||||
NRAS | GTPase NRas. (230 aa) | ||||
PIK3R1 | Phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1. (724 aa) | ||||
SP1 | Transcription factor Sp1. (787 aa) | ||||
MYC | Myc proto-oncogene protein. (438 aa) | ||||
ERBB2 | Receptor tyrosine-protein kinase erbB-2. (1255 aa) | ||||
RPS6KB1 | Ribosomal protein S6 kinase beta-1. (525 aa) | ||||
DVL1 | Segment polarity protein dishevelled-like protein DVL-1. (695 aa) | ||||
JAG1 | Protein jagged-1. (1279 aa) | ||||
RB1 | Retinoblastoma-associated protein. (929 aa) | ||||
APC | Adenomatous polyposis coli protein. (2873 aa) | ||||
GRB2 | Growth factor receptor-bound protein 2. (217 aa) | ||||
WNT3A | Protein Wnt-3a. (352 aa) | ||||
WNT9A | Protein Wnt-9a. (389 aa) | ||||
GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha. (165 aa) | ||||
HRAS | GTPase HRas. (265 aa) | ||||
WNT1 | Proto-oncogene Wnt-1. (370 aa) | ||||
PIK3CB | Phosphatidylinositol 4. (1070 aa) | ||||
WNT10B | Protein Wnt-10b. (389 aa) | ||||
FGF1 | Fibroblast growth factor 1. (155 aa) | ||||
PTEN | Phosphatase and tensin homolog. (403 aa) | ||||
DLL3 | Delta-like protein 3. (640 aa) | ||||
FRAT1 | Proto-oncogene FRAT1. (279 aa) | ||||
LRP5L | Low-density lipoprotein receptor-related protein 5. (352 aa) | ||||
GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta. (160 aa) | ||||
FZD4 | Frizzled-4. (537 aa) | ||||
FGF17 | Fibroblast growth factor 17. (216 aa) | ||||
NCOA1 | Nuclear receptor coactivator 1. (1441 aa) | ||||
EGF | Pro-epidermal growth factor isoform X1. (1206 aa) | ||||
MAPK3 | Mitogen-activated protein kinase 3. (377 aa) | ||||
TP53 | Cellular tumor antigen p53. (381 aa) | ||||
AXIN1 | Axin-1. (867 aa) | ||||
TNFSF11 | Tumor necrosis factor ligand superfamily member 11. (270 aa) | ||||
LRP6 | Low-density lipoprotein receptor-related protein 6. (1613 aa) | ||||
IGF1 | Insulin-like growth factor I. (194 aa) | ||||
AKT2 | Cyclin N-terminal domain-containing protein 2. (481 aa) | ||||
ENSCDRP00005014931 | LOW QUALITY PROTEIN: casein kinase I-like. (298 aa) | ||||
GSK3B | Glycogen synthase kinase-3 beta isoform X1. (433 aa) | ||||
RPS6KB2 | Ribosomal protein S6 kinase beta-2. (485 aa) | ||||
NOTCH3 | Neurogenic locus notch-like protein 3. (2331 aa) | ||||
BRCA1 | Breast cancer type 1 susceptibility protein-like protein. (1842 aa) | ||||
CDKN1A | Cyclin-dependent kinase inhibitor 1. (164 aa) | ||||
NCOA3 | Nuclear receptor coactivator 3. (1428 aa) | ||||
PIK3R2 | Phosphatidylinositol 3-kinase regulatory subunit beta. (723 aa) | ||||
WNT7B | Protein Wnt-7b. (538 aa) | ||||
PIK3CD | Phosphatidylinositol 4. (1044 aa) | ||||
HEYL | Hairy/enhancer-of-split related with YRPW motif-like protein. (328 aa) | ||||
LEF1 | Lymphoid enhancer-binding factor 1. (414 aa) | ||||
AKT3 | RAC-gamma serine/threonine-protein kinase isoform X3. (479 aa) | ||||
HES1 | Transcription factor HES-1. (280 aa) | ||||
FGFR1 | Fibroblast growth factor receptor 1. (852 aa) | ||||
NFKB2 | Nuclear factor NF-kappa-B p100 subunit. (899 aa) | ||||
WNT4 | Protein Wnt-4. (350 aa) | ||||
FGF10 | Fibroblast growth factor 10. (209 aa) | ||||
SOS1 | Son of sevenless-like protein 1. (1333 aa) | ||||
HEY1 | Hairy/enhancer-of-split related with YRPW motif protein 1. (308 aa) | ||||
ENSCDRP00005021887 | Fibroblast growth factor 9. (112 aa) | ||||
EGFR | Epidermal growth factor receptor. (1137 aa) | ||||
ARAF | Serine/threonine-protein kinase A-Raf. (606 aa) | ||||
WNT5A | Protein Wnt-5a. (430 aa) | ||||
FZD5 | Frizzled-5. (673 aa) | ||||
FZD6 | Frizzled-6. (712 aa) | ||||
MTOR | Serine/threonine-protein kinase mTOR. (2546 aa) | ||||
SHC3 | SHC-transforming protein 3. (441 aa) | ||||
TCF7L1 | Transcription factor 7-like 1. (547 aa) | ||||
GADD45G | Growth arrest and DNA damage-inducible protein GADD45 gamma. (159 aa) | ||||
FGF8 | Fibroblast growth factor 8. (243 aa) | ||||
RAF1 | RAF proto-oncogene serine/threonine-protein kinase. (668 aa) | ||||
E2F2 | Transcription factor E2F2. (437 aa) | ||||
E2F3 | Transcription factor E2F3. (462 aa) | ||||
DLL1 | Delta-like protein 1. (722 aa) | ||||
PIK3R3 | Phosphatidylinositol 3-kinase regulatory subunit gamma. (461 aa) | ||||
FGF22 | Fibroblast growth factor 22. (170 aa) | ||||
WNT8B | Protein Wnt-8b. (351 aa) | ||||
FZD7 | Frizzled-7. (574 aa) | ||||
FGF7 | Fibroblast growth factor 7. (194 aa) | ||||
SHC4 | SHC-transforming protein 4. (630 aa) | ||||
IGF1R | Insulin-like growth factor 1 receptor. (1299 aa) | ||||
CDK4 | Cyclin-dependent kinase 4. (303 aa) | ||||
FZD3 | Frizzled-3. (666 aa) | ||||
BRCA2 | Breast cancer type 2 susceptibility protein-like protein. (3413 aa) | ||||
KRAS | GTPase KRas. (189 aa) | ||||
CTNNB1 | Catenin beta-1. (783 aa) | ||||
AXIN2 | Axin-2. (843 aa) | ||||
DVL2 | Segment polarity protein dishevelled-like protein DVL-2. (736 aa) | ||||
ESR1 | Estrogen receptor. (307 aa) | ||||
FGF16 | Fibroblast growth factor 16. (207 aa) | ||||
TCF7L2 | Transcription factor 7-like 2. (377 aa) | ||||
NOTCH4 | Neurogenic locus notch-like protein 4. (1990 aa) | ||||
FGF4 | Fibroblast growth factor 4. (243 aa) | ||||
FGF19 | Fibroblast growth factor 19. (219 aa) | ||||
BAK1 | Bcl-2 homologous antagonist/killer. (211 aa) | ||||
WNT3 | Proto-oncogene Wnt-3. (355 aa) | ||||
MAPK1 | Mitogen-activated protein kinase 1. (359 aa) | ||||
FZD1 | Frizzled-1. (617 aa) | ||||
WNT5B | Protein Wnt-5b. (361 aa) | ||||
FGF6 | Fibroblast growth factor 6. (208 aa) |